M&A Deal Summary

Endurance RP Acquires Deep Longevity

On September 3, 2020, Endurance RP acquired information technology company Deep Longevity for 4M USD

Acquisition Highlights
  • This is Endurance RP’s 1st transaction in the Information Technology sector.
  • This is Endurance RP’s largest (disclosed) transaction.
  • This is Endurance RP’s 1st transaction in China.

M&A Deal Summary
Date 2020-09-03
Target Deep Longevity
Sector Information Technology
Buyer(s) Endurance RP
Deal Type Add-on Acquisition
Deal Value 4M USD

Target

Deep Longevity

Hong Kong, China
Deep Longevity, Inc. is a developer of an artificial intelligence systems to track the rate of aging at the molecular, cellular, tissue, organ, system, physiological, and psychological levels. Deep Longevity is based in Hong Kong.

Search 198,123 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Endurance RP

Hong Kong, China
Category Company
Founded 1991
Sector Financial Services
Employees17
Revenue 3M HKD (2021)
DESCRIPTION

Endurance RP is a diversified investment group based in Hong Kong currently holding various corporate and strategic investments focusing on the healthcare and life sciences sectors. The company engages in the research, development, manufacture, marketing, and sale of pharmaceutical products. It focuses on the commercialization of Fortacin, a topical prescription treatment for premature ejaculation. Endurance RP was founded in 1991 and is based in Hong Kong.

DEAL STATS #
Overall 2 of 2
Sector (Information Technology) 1 of 1
Type (Add-on Acquisition) 2 of 2
Country (China) 1 of 1
Year (2020) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-03-10 Plethora Solutions Holdings

London, United Kingdom

Plethora Solutions Holdings PLC is a specialist pharmaceutical business focused on developing products for the treatment and management of urological disorders. Plethora was founded in 2003, before being listed on AIM in 2005. The company has grown in response to increasing demand for its products which serve a large, growing patient population whose medical needs are currently poorly met. Plethora has grown from a cash consumptive development company into a sustainable urology business benefiting from both near term product sales and high value, medium term licensing income.

Buy -
Mergr

Product

Company

Legal